Evidence map›Paper›PMID 18953408›Full record

ArticlePloS one2008

Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk.

Yan Ding, Garrett Larson, Guillermo Rivas, Cathryn Lundberg, Louis Geller, Ching Ouyang, Jeffrey Weitzel, John Archambeau, Jerry Slater, Mary B Daly and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evolutionary molecular medicine.Journal of molecular medicine (Berlin, Germany) · 2012
    Review
  7. Article
  8. Article
  9. Allelic imbalance and abnormal expression of FHIT in endemic nasopharyngeal carcinoma: association with clinicopathological features.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 1 country.

Yan DingDivision of Molecular Medicine, Beckman Research Institute of the City of Hope, Duarte, California, USA.
Garrett Larson
Guillermo Rivas
Cathryn Lundberg
Louis Geller
Ching Ouyang
Jeffrey Weitzel
John Archambeau
Jerry Slater
Mary B Daly
Al B Benson
John M Kirkwood
Peter J O'Dwyer
Rebecca Sutphen
James A Stewart
David Johnson
Magnus Nordborg
Theodore G Krontiris
City of Hope · USBeckman Research InstituteLoma Linda University · USCancer Genetics (United States) · USCity Of Hope National Medical Center · USFox Chase Cancer Center · USNorthwestern University · USSouthern California University for Professional Studies · USUniversity of Pennsylvania · USUniversity of South Florida · USUPMC Hillman Cancer Center · USVanderbilt University · US

Funding

Implications of haplotype structure in the human genomeP50HG002790 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TAVARE, SIMON · 2003 to 2013
$29.9M
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
Population-Based Analysis of Ovarian Cancer BiomarkersR01CA106414 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI SUTPHEN, REBECCA · 2005 to 2009
$3.0M
MAPPING INTERACTIVE CANCER SUSCEPTIBILITY LOCIR01AG015720 · NIA · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI KRONTIRIS, THEODORE G · 1997 to 2002
$2.6M
Clinical Cancer Genetics Community Network: A Sustainable Research PartnershipRC4CA153828 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WEITZEL, JEFFREY N · 2010 to 2010
$1.0M
NCI NIH HHS R01 CA106414NCI NIH HHS RC4 CA153828NCRR NIH HHS UL1 RR025741NHGRI NIH HHS HG-002790NHGRI NIH HHS P50 HG002790NIA NIH HHS AG15720
6 · The paper itself

Abstract

Previously, a candidate gene linkage approach on brother pairs affected with prostate cancer identified a locus of prostate cancer susceptibility at D3S1234 within the fragile histidine triad gene (FHIT), a tumor suppressor that induces apoptosis. Subsequent association tests on 16 SNPs spanning approximately 381 kb surrounding D3S1234 in Americans of European descent revealed significant evidence of association for a single SNP within intron 5 of FHIT. In the current study, re-sequencing and genotyping within a 28.5 kb region surrounding this SNP further delineated the association with prostate cancer risk to a 15 kb region. Multiple SNPs in sequences under evolutionary constraint within intron 5 of FHIT defined several related haplotypes with an increased risk of prostate cancer in European-Americans. Strong associations were detected for a risk haplotype defined by SNPs 138543, 142413, and 152494 in all cases (Pearson's chi(2) = 12.34, df 1, P = 0.00045) and for the homozygous risk haplotype defined by SNPs 144716, 142413, and 148444 in cases that shared 2 alleles identical by descent with their affected brothers (Pearson's chi(2) = 11.50, df 1, P = 0.00070). In addition to highly conserved sequences encompassing SNPs 148444 and 152413, population studies revealed strong signatures of natural selection for a 1 kb window covering the SNP 144716 in two human populations, the European American (pi = 0.0072, Tajima's D = 3.31, 14 SNPs) and the Japanese (pi = 0.0049, Fay & Wu's H = 8.05, 14 SNPs), as well as in chimpanzees (Fay & Wu's H = 8.62, 12 SNPs). These results strongly support the involvement of the FHIT intronic region in an increased risk of prostate cancer.

Indexed as

Genetic Predisposition to DiseaseIntronsSelection, GeneticAcid Anhydride HydrolasesBis(5'-adenosyl)triphosphataseCase-Control StudiesDNA Mutational AnalysisGene Expression ProfilingGene FrequencyHumansLinkage DisequilibriumMaleNeoplasm ProteinsPolymorphism, Single NucleotideProstatic NeoplasmsRisk FactorsAcid Anhydride HydrolasesBis(5'-adenosyl)triphosphataseNeoplasm Proteins

Identifiers

PMID18953408
PMCPMC2568805
OpenAlexW2134959429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.